Novartis: No more R&D investments in India

04/8/2013 | BBC

Novartis will no longer invest in pharmaceutical research and development in India after the Supreme Court refused to grant patent protection on the company's cancer drug Glivec, says Ranjit Shahani, vice chairman and managing director of Novartis India. Other drugmakers probably will do the same, Shahani says.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ